Updated on 8 January 2025
Fueling the Future of Precision Antimicrobials
About
Phagestack is building an integrated platform for precision antimicrobials, combining proprietary data, AI-driven discovery, experimental validation, and scalable production. By owning the full value chain, we aim to compress development timelines, create multiple revenue streams, and build a defensible position in a rapidly growing global market. We are seeking a lead investor to accelerate scale-up and unlock an existing institutional soft commitment.
Stage
- Startup